Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Defrancesco, Michaela ^a   Egger, Karl ^c   Marksteiner, Josef ^b   Esterhammer, Regina ^a   Hinterhuber, Hartmann ^a   Deisenhammer, Eberhard A ^a   Schocke, Michael ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Department of Radiology I Innsbruck Medical University ^*  (Austria)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ATROPHY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GRAY MATTER; GRAY MATTER ATROPHY; HEMISPHERE; HIGH RISK POPULATION; HUMAN; INSULA; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; OCCIPITAL LOBE; PARAHIPPOCAMPAL GYRUS; PARIETAL LOBE; PUTAMEN; RETROSPECTIVE STUDY; TEMPORAL LOBE; VERBAL MEMORY; VISUAL MEMORY; VOXEL BASED MORPHOMETRY; WHITE MATTER; AGED; BRAIN MAPPING; CASE CONTROL STUDY; DISEASE COURSE; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROCEDURES;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN MAPPING; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GRAY MATTER; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; WHITE MATTER;

EID: 84923224313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106062     Document Type: Article

References (54)

1. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, et al. (2001) Current concepts in mild cognitive impairment. Arch Neurol 58: 1985-92. (Pubitemid 33143977)
2. Ritchie K, Touchon J (2000) Mild cognitive impairment: conceptual basis and current nosological status. Lancet 355: 225-8. (Pubitemid 30068229)
3. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256: 183-194.
4. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) "Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease". Neurology 34: 939-44. (Pubitemid 14076461)
5. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, el al. (1999) Mild cognitive impairment - Clinical characterization and outcome. Arch Neurol 56: 303-8. (Pubitemid 29120227)
6. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet neurol 9: 119-128.
7. Holtzman DM, Morris JC, Goate AM (2011) Alzheimer's disease: the challenge of the second century. Sci transl med 3: 77-71.
8. Rosén C, Hansson O, Blennow K, Zetterberg H (2013) Fluid biomarkers in Alzheimer's disease - current concepts. Mol Neurodegener 21: 8-20.
9. Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, et al. (2012) Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. Lancet neurology 11: 1057-65.
10. Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, et al. (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet neurol 11: 669-678.
11. Mintun MA, LaRossa GN, Sheline YI, et al. (2006) PIB in a nondemented population - Potential antecedent marker of Alzheimer disease. Neurology 67: 446-52. (Pubitemid 44214969)
12. Gold BT, Johnson NF, Powell DK, Smith CD (2012) White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions. Biochim Biophys Acta 1822: 416-22.
13. Karas G, Sluimer J, Goekoop R, van der Flier W, Rombouts SA, et al. (2008) Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. Am J Neurorad 229: 944-9. (Pubitemid 351684972)
14. Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, et al. (2012) Impact of White Matter Lesions and Cognitive Deficits on Conversion from Mild Cognitive Impairment to Alzheimer's Disease. J Alzheimers Dis 34: 665-672.
15. Chong MS, Sahadevan S (2005) Preclinical Alzheimer's disease: diagnosis and prediction of progression. Lancet Neurol 4: 576-579. (Pubitemid 41139979)
16. Reiman EM, Langbaum JB, Tariot PN (2010) Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med 4: 3-14.
17. Braak H, Braak E (1991) Alzheimers-Disease Affects Limbic Nuclei of the Thalamus. Acta Neuropathol 81: 261-8.
18. Braak H, Braak E (1991) Neuropathological Staging of Alzheimer-Related Changes. Acta Neuropathol 82: 239-59.
19. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, et al. (2009) Age, Neuropathology, and Dementia. N Engl J Med 360: 2302-9.
20. Koivunen J, Scheinin N, Virta JR, et al. (2011) Amyloid PET imaging in patients with mild cognitive impairment A 2-year follow-up study. Neurology 76: 1085-90.
21. Rowe CC, Ng S, Ackermann U, Gong SJ, et al. (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68: 1718-25. (Pubitemid 46763260)
22. Cherubini A, Spoletini I, Peran P, et al. (2010) A multimodal MRI investigation of the subventricular zone in mild cognitive impairment and Alzheimer's disease patients. Neurosci Lett 469: 214-8.
23. Good CD, Johnsrude IS, Ashburner J, Henson RNA, Friston KJ, et al. (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: 21-36. (Pubitemid 32552740)
24. Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, et al. (2001) In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 14: 298-309. (Pubitemid 32709545)
25. Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, et al. (2009) Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort. Curr Alzheimer Res 6: 347-61.
26. Chetelat G, Landeau B, Eustache F, Mézenge F, Viader F, et al. (2005) Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 27: 934-46. (Pubitemid 41317262)
27. Hämäläinen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, et al. (2007) Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage 37: 1122-31. (Pubitemid 47385281)
28. Colliot O, Chételat G, Chupin M, Desgranges B, Magnin B, et al. (2008) Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 248: 194-201.
29. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, et al. (2001) Mild cognitive impairment and Alzheimer disease: Regional diffusivity of water. Radiology 219: 101-7. (Pubitemid 32234060)
30. Cherubini A, Péran P, Spoletini I, Di Paola M, Di Iulio F, et al. (2010) Combined Volumetry and DTI in Subcortical Structures of Mild Cognitive Impairment and Alzheimer's Disease Patients. J Alzheimers Dis 19: 1273-82.
31. Ray KM, Wang H, Chu Y, Chen YF, Bert A, et al. (2006) Mild cognitive impairment: Apparent diffusion coefficient in regional gray matter and white matter structures. Radiology 241: 197-205. (Pubitemid 44433351)
32. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, et al. (2005) DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64: 902-4. (Pubitemid 40316336)
33. Satzger W, Hampel H, Padberg F, Bürger K, Nolde T, et al. (2001) Practical application of the CERAD test battery in screening for neuropsychological dementia. Nervenarzt 72: 196-203. (Pubitemid 32215560)
34. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR Signal Abnormalities at 1.5-T in Alzheimers Dementia and Normal Aging. Am J - Neuroradiol 8: 421-6. (Pubitemid 17075726)
35. Morris JC, McKeel DW, Fulling K, Torack RM, Berg L (1988) Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 24: 17-22.
36. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-98.
37. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8: 271-6.
38. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, et al. (1983) Development and Validation of A Geriatric Depression Screening Scale - A Preliminary-Report. J Psychiatr Res 17: 37-49.
39. Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, et al. (2004) Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 21: 1443-51. (Pubitemid 38446570)
40. Hakulinen U, Brander A, Ryymin P, Öhman J, Soimakallio S, et al. (2012) Repeatability and variation of region-of-interest methods using quantitative diffusion tensor MR imaging of the brain. BMC Med Imaging 12: 30.
41. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage. 38: 95-113.
42. Levin JR, Serlin RC, Seaman MA (1994) A controlled, powerful multiple-comparison strategy for several situations. Psychol. Bull. 115: 153-159. (Pubitemid 24976741)
43. Wang PJ, Saykin AJ, Flashman LA, Wishart HA, Rabin LA, et al. (2006) Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints. Neurobiol Aging 27: 1613-7. (Pubitemid 44344845)
44. Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, et al. (2001) Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358: 201-5. (Pubitemid 32718544)
45. Chetelat G, Landeau B, Eustache F, Mézenge F, Viader F, et al. (2005) Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 27: 934-46. (Pubitemid 41317262)
46. Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV (2011) Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies. Neurobiol Aging 32: 1733-41.
47. Hamalainen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, et al. (2007) Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage 37: 1122-31. (Pubitemid 47385281)
48. Korf ESC, Wahlund LO, Visser PJ, Scheltens P (2004) Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 63: 94-100. (Pubitemid 38943785)
49. Zhuang L, Sachdev PS, Trollor JN, Reppermund S, Kochan NA, et al. (2013) Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PLoS One 8: e58887.
50. Liu J, Yin C, Xia S, Jia L, Guo Y, et al. (2013) White matter changes in patients with amnestic mild cognitive impairment detected by diffusion tensor imaging. PLoS One 3: e58887.
51. Jack CR, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, et al. (2004) Comparison of different MRI brain atrophy, rate measures with clinical disease progression in AD. Neurology 62: 591-600. (Pubitemid 38252801)
52. Smith CD, Chebrolu H, Andersen AH, Powell DA, Lovell MA, et al. (2010) White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol Aging 31: 1122-1131.
53. Tisserand DJ, van Boxtel MPJ, Pruessner JC, Hofman P, Evans AC, et al. (2004) A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. Cereb Cortex 14: 966-73. (Pubitemid 39121358)
54. Sandson TA, Felician O, Edelman RR, Warach S (1999) Diffusion-weighted magnetic resonance imaging in Alzheimer's disease. Dement Geriatr Cogn Disord 10: 166-71. (Pubitemid 29099702)